Status:
COMPLETED
REmote Assessment and Dynamic Response Intervention II
Lead Sponsor:
Oregon Health and Science University
Collaborating Sponsors:
National Institute on Aging (NIA)
Conditions:
Dementia
Alzheimer Disease
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The purpose of the READyR II Study is to test a dynamic tailoring phase of a remote assessment for changing dementia-related care needs.
Detailed Description
Unmet dementia-related care needs are highly prevalent, and are detrimental to the care dyad's (person with dementia and their family care partner) health, safety, mortality, and likelihood of nursing...
Eligibility Criteria
Inclusion
- 62 years or older;
- Able to identify a family care partner over age 20 who is living with you and will also consent to fully participate in the study
- Probable or confirmed diagnosis of mild cognitive impairment or early-stage dementia
- Age and education adjusted MOCA score \> 15 (at most recent measurement by parent study) corresponding to early to moderate stage dementia
Exclusion
- Inability to speak English or read printed materials in English
- Conditions that would limit participation at entry to study (e.g. visual or hearing impairments prohibiting reading and discussing the intervention materials)
- Any uncontrolled medical condition that is expected to preclude completion of the study, such as late stage cancers
- Family Care Partners
- Inclusion:
- 21 years or older;
- Self-identifying as a family member and care partner residing with the PwD participant;
- Exclusion:
- Inability to speak English or read printed materials in English
- Conditions that would limit participation at entry to study (e.g. visual or hearing impairments prohibiting reading and discussing the intervention materials);
- Any uncontrolled medical condition that is expected to preclude completion of the study, such as late stage cancers.
Key Trial Info
Start Date :
July 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 25 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04686838
Start Date
July 1 2021
End Date
November 25 2022
Last Update
January 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Science University
Portland, Oregon, United States, 97239